The profile you requested (/company/the-university-of-the-west-indies) does not exist or is not published.
Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
3Bar Biologics
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of a sustainable microbe inoculant system that helps farmers increase crop yield without having to change the way they plant

Founded in 2013
Founded in

Company type Private Public ()
Company type

Industry Group agriculture & food

Sector crop inputs

TRL Range 4-6
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Columbus, OH Columbus, United States
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Henri Vansoest at on 04/20/2017

Edited by Cleantech Group on 06/08/2021

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
03/20/2019
Pivot Bio Pivot Bio
3Bar and Pivot Bio are working on a on-site microbial growing technology. They are currently marketing the product through traditional retail channels like coops. The average price is $5 per acre and the company’s field trials have shown an average yield increase of 7 to 8 bushels per acre, which equates to about $30 per acre.
View source    
Confirmed by Pivot Bio
Technology Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Cancel Save
Add Investment
Date Investors Type Amount
08/16/2017 Rev1 Ventures Rev1 Ventures , Maumee Ventures Maumee Ventures , Ohio TechAngel Funds Ohio TechAngel Funds , Queen City Angels (QCA) Queen City Angels (QCA) , Carmen Innovations Carmen Innovations , SVG Thrive Fund SVG Thrive Fund (6)
Post-money valuation of
This round total of $2 million corresponds with the target in previous SEC filings. The funding will be used to broaden availability of 3Bar Biologics' products.
 Series A $2,000,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font